Oral Administration of Herbal Mixture Extract Inhibits 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in BALB/c Mice

Mediators of Inflammation - Tập 2014 - Trang 1-10 - 2014
Soon Re Kim1, Han‐Seok Choi1, Hye Sook Seo1, Jin Mo Ku1, Se Hyang Hong1, Hye Hyun Yoo2, Yong Cheol Shin1, Seong‐Gyu Ko1
1Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130–701, Republic of Korea
2Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 426–791, Republic of Korea

Tóm tắt

CP001 is four traditional herbal medicine mixtures with anti-inflammatory properties. In this study, we investigated the effect of oral administration of CP001 ethanol extract on the 2,4-dinitrochlorobenzene- (DNCB-) induced AD mouse models. For that purpose, we observed the effects of oral administration of CP001 on skin inflammatory cell infiltration, skin mast cells, production of serum IgE, and expression of Th2 cytokine mRNA in the AD skin lesions of DNCB treated BALB/c mice. Histological analyses demonstrated that CP001 decreased dermis and epidermis thickening as well as dermal infiltration induced by inflammatory cells. In addition, CP001 decreased mast cell infiltration in count as well as dermal infiltration induced by inflammatory cells. In the skin lesions, mRNA expression of interleukin- (IL-) 4 and IL-13 was inhibited by CP001. CP001 also reduced the production of IgE level in mouse plasma. In addition, we investigated the effect of CP001 on the inflammatory allergic reaction using human mast cells (HMC-1). In HMC-1, cytokine production and mRNA levels of IL-4, IL-13, IL-6, and IL-8 were suppressed by CP001. Taken together, our results showed that oral administration of CP001 exerts beneficial effects in AD symptoms, suggesting that CP001 might be a useful candidate for the treatment of AD.

Từ khóa


Tài liệu tham khảo

10.1111/j.1398-9995.2006.01153.x

10.1172/JCI200421060

10.1001/archderm.112.9.1254

10.1038/nm.2755

10.1093/intimm/9.3.461

10.4172/2155-9899.1000110

1993, The Journal of Immunology, 151, 3853, 10.4049/jimmunol.151.7.3853

10.1016/0091-6749(92)90107-D

10.1111/j.1398-9995.2005.00886.x

1993, Journal of Immunology, 151, 3261, 10.4049/jimmunol.151.6.3261

10.1142/S0192415X09006734

10.3892/or_00000535

10.1016/j.jep.2008.02.018

10.1016/j.jep.2010.11.050

10.1142/S0192415X11009482

10.1016/S0192-0561(98)00037-X

10.1006/phrs.1999.0504

10.1111/j.1365-3164.2009.00796.x

10.1016/j.jep.2007.11.042

10.1016/j.jep.2011.03.005

2007, Nutritiona Research and Practice, 1, 279, 10.4162/nrp.2007.1.4.279

2008, Nutritiona Research and Practice, 2, 143, 10.4162/nrp.2008.2.3.143

10.1155/2012/545497

1998, Postgraduate Medicine, 103, 199, 10.3810/pgm.1998.05.486

10.1016/j.jep.2010.11.020

10.1016/j.jep.2010.08.002

10.1073/pnas.88.10.4220

1992, Journal of Immunology, 148, 1086, 10.4049/jimmunol.148.4.1086

1994, Blood, 84, 1913, 10.1182/blood.V84.6.1913.1913

10.1046/j.0022-202X.2001.01484.x

Thông tin
Thông tin xuất bản

Mediators of Inflammation

Tập 2014

1-10

Thông tin tác giả